Prognostic elements in sufferers with metastatic backbone tumors derived from lung cancer-a novel scoring system for predicting life expectancy.
World J Surg Oncol. 2018 Jul 05;16(1):131
Authors: Uei H, Tokuhashi Y
BACKGROUND: Just lately, molecule-targeting and bone-modifying brokers have improved the remedy outcomes of lung cancer-derived metastatic backbone tumors. Subsequently, the prognostic elements for such tumors have been examined, and novel scoring programs for predicting the life expectancy of sufferers with such tumors have been proposed.
METHODS: In 207 sufferers with lung cancer-derived metastatic backbone tumors (surgical procedure 49; conservative remedy 158), we retrospectively examined the elements that influenced the post-treatment survival time (age, intercourse, the affected web site, pathology, common situation, the variety of extraspinal bone metastases, the variety of spinal metastases, the presence/absence of main inner organ metastasis, paralysis state, the overall Tokuhashi rating, the serum alkaline phosphatase stage, the serum carcinoembryonic antigen stage, molecule-targeting drug remedy, and bone-modifying agent remedy). Primarily based on the outcomes, we devised novel scoring programs for predicting the prognosis of such sufferers.
RESULTS: Univariate analyses confirmed that the pathology of the first lung tumor, the affected person’s common situation and paralysis state, and the presence/absence of molecule-targeting drug remedy considerably influenced survival. We carried out a Cox regression evaluation of those 4 elements and developed standards for a novel scoring system based mostly on the affected person’s common situation and paralysis state, which exhibited significance within the regression evaluation. A retrospective evaluation indicated that the consistency fee between predicted life expectancy and precise survival was 67.three%. When standards based mostly on the 4 elements that exhibited significance within the univariate analyses have been adopted, the consistency fee was 76.2%.
CONCLUSION: The affected person’s common situation and paralysis state, the pathology of the first lung tumor, and molecule-targeting drug remedy influenced survival amongst sufferers with lung cancer-derived metastatic backbone tumors. Novel scoring programs based mostly on these 4 elements have been proposed.
PMID: 29976208 [PubMed – in process]